A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder (European Archives of Psychiatry and Clinical Neuroscience (2009) 259, (120-129) DOI: 10.1007/s00406-008-0845-4);A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder

European Archives of Psychiatry and Clinical Neuroscience

Volumn 259, Issue 2, 2009, Pages 120-129

  Rösler, Michael ^a   Fischer, Roland ^b   Ammer, Richard ^b   Ose, Claudia ^c   Retz, Wolfgang ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b MEDICE Arzneimittel Pütter GmbH Co KG   (Germany)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

ADHD; Adults; Efficacy; Long term; Methylphenidate; Placebo; Randomized trial

Indexed keywords

METHYLPHENIDATE; PLACEBO; THYROXINE; TRIACYLGLYCEROL; URIC ACID;

ADULT; AKATHISIA; ARTICLE; ATAXIA; ATTENTION DEFICIT DISORDER; BLOOD CELL COUNT; BLOOD CLOTTING TEST; BLURRED VISION; BODY WEIGHT; BREATHING DISORDER; CHILL; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECREASED APPETITE; DELAYED DRUG RELEASE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIARRHEA; DIASTOLIC BLOOD PRESSURE; DISORIENTATION; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG DOSE TITRATION; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSKINESIA; EMOTIONAL DISORDER; FEMALE; HEART DISEASE; HEART PALPITATION; HEART RATE; HOT FLUSH; HUMAN; HYPERACTIVITY; HYPERHIDROSIS; HYPOKINESIA; IMPULSIVENESS; INCREASED APPETITE; LEG DISEASE; LIBIDO DISORDER; LOW DRUG DOSE; MAINTENANCE DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MENSTRUATION; MENTAL INSTABILITY; MICTURITION DISORDER; MULTICENTER STUDY; MUSCLE TONE; NAUSEA; NYSTAGMUS; OPTIMAL DRUG DOSE; PARALLEL DESIGN; PARESTHESIA; PATIENT COMPLIANCE; POLYDIPSIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RIGOR; SEBORRHEA; SIDE EFFECT; SLEEP DISORDER; SYSTOLIC BLOOD PRESSURE; TEMPERAMENT; THYROXINE BLOOD LEVEL; TREATMENT DURATION; TREATMENT RESPONSE; TREMOR; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; VOMITING; XEROSTOMIA;

EID: 60649101658     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00406-009-0005-5     Document Type: Erratum

References (37)

1. LA Adler TJ Spencer LR Levine JL Ramsey R Tamura D Kelsey SG Ball AJ Allen J Biederman 2008 Functional outcomes in the treatment of adults with ADHD J Atten Disord 11 720 727
2. Arbeitgemeinschaft für Methodik und Dokumentation in der Psychiatrie (2006) Das AMDP-System. 8. überarbeitet Auflage. Göttingen, Hogrefe
3. T Banaschewski D Coghill P Santosh A Zuddas P Asherson J Buitelaar M Danckaerts M Doepfner SV Faraone A Rothenberger J Sergeant HC Steinhausen EJS Sonuga-Barke E Taylor 2006 Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guidelines Eur Child Adolesc Psychiatry 15 476 495
4. J Biederman E Mick C Surman R Doyle P Hammerness T Harpold S Dunkel M Dougherty M Aleardi T Spencer 2006 A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder Biol Psychiatry 59 829 835
5. R Bouffard L Hechtman K Minde F Iaboni-Kassab 2003 The efficacy of 2 different dosages of methylphenidate in treating adults with attention-deficit hyperactivity disorder Can J Psychiatry 48 546 554
6. Conners CK, Erhardt D, Sparrow E (1999) CAARS Conners adult ADHD rating scales. MHS, New York
7. DuPaul GJ, Power TJ, Anastopoulos AD, Reid R (1998) ADHD rating scale-IV. Guilford, New York
8. D Ebert J Krause C Roth-Sackenheim The DGPPN Expert Committee 2003 ADHD in adulthood-guidelines based on expert consensus with DGPPN support Nervenarzt 74 939 946
9. SV Faraone T Spencer M Aleardi C Pagano J Biederman 2004 Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/ hyperactivity disorder J Clin Psychopharmacol 24 24 29
10. J Fayyad R De Graf R Kessler J Alonso M Angermeyer K Demyttenaere G De Girolamo M Haro EG Karam C Lara JP Lepine J Ormel J Posada-Villa AM Zaslavsky T Jin 2007 Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder Brit J Psychiatry 190 402 409
11. CT Gualtieri MG Ondrusek C Finley 1985 Attention deficit disorders in adults Clin Neuropharmacol 8 343 356
12. Guy W, Ban TA (1982) The AMDP system. A manual for the assessment and documentation in psychopathology. Springer, Berlin
13. U Jain L Hechtman M Weiss TS Ahmed JL Reiz GAE Donnelly Z Harsany AC Darke 2007 Efficacy of a novel biphasic controlled-release methylphenidate formula in adults with attention-deficit/hyperactivity disorder: results of a double-blind, placebo-controlled crossover study J Clin Psychiatry 68 268 277
14. JJ Kooij H Burger AM Boonstra PD van der Linden LE Kalma JK Buitelaar 2004 Efficacy and safety of methylphenidate in 45 adults with attention-deficit/hyperactivity disorder. A randomized placebo-controlled double-blind cross-over trial Psychol Med 34 973 982
15. S Kuperman PJ Perry GR Gaffney BC Lund KA Bever-Stille S Arndt TL Holman DJ Moser JS Paulsen 2001 Bupropion SR vs. methylphenidate vs. placebo for attention deficit hyperactivity disorder in adults Ann Clin Psychiatry 13 129 134
16. JA Mattes L Boswell H Oliver 1984 Methylphenidate effects on symptoms of attention deficit disorder in adults Arch Gen Psychiatry 41 1059 1063
17. Medori R, Ramos-Quiroga JA, Casas M, Kooij JJ, Niemelä A, Trott GE, Lee E, Buitelaar JK (2008) A randomized placebo-controlled trial of three fixed dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry [epub ahead of print]
18. D Michelson L Adler T Spencer FW Reimherr SA West AJ Allen D Kelsey J Wernicke A Dietrich D Milton 2003 Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies Biol Psychiatry 53 112 120
19. National 2008 Attention deficit hyperactivity disorder pharmacological
20. NIMH 1985 Psychopharmacol Bull 21 839
21. DJ Nutt K Fone P Asherson D Bramble P Hill K Matthews KA Morris P Santosh E Sonuga-Barke E Taylor M Weiss S Young 2007 Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology J Psychopharmacol 21 10 41
22. FW Reimherr BK Marchant RE Strong DW Hedges L Adler TJ Spencer SA West P Soni 2005 Emotional dysregulation in adult ADHD and response to atomoxetine Biol Psychiatry 58 125 131
23. FW Reimherr ED Williams RE Strong R Mestas P Soni BK Marchant 2007 A double-blind, placebo-controlled, crossover study of osmotic release oral system methylphenidate in adults with ADHD with assessment of oppositional and emotional dimensions of the disorder J Clin Psychiatry 68 93 101
24. P Retz-Junginger W Retz D Blocher RD Stieglitz T Georg T Supprian PH Wender M Rösler 2003 Reliability and validity of the Wender-Utah-rating- scale short form. Retrospective assessment of symptoms for attention deficit/hyperactivity disorder Nervenarzt 74 987 993
25. P Retz-Junginger W Retz D Blocher HG Weijers GE Trott PH Wender M Rösler 2002 Wender Utah rating scale. The short-version for the assessment of the attention-deficit hyperactivity disorder in adults Nervenarzt 73 830 838
26. M Rösler W Retz P Retz-Junginger RD Stieglitz F Reimherr P Wender 2008 Attention deficit-/hyperactivity disorder (ADHD) in adults: benchmarking diagnosis using the Wender-Reimherr Adult ADHD Rating Scale (WRAADDS) Nervenarzt 79 320 327
27. Rösler M, Retz W, Retz-Junginger P, Stieglitz RD, Reimherr F, Wender P (2008) Homburger ADHS Skalen für Erwachsene (HASE). Hogrefe, Göttingen
28. M Rösler W Retz J Thome M Schneider R-D Stieglitz P Falkai 2006 Psychopathological rating scales for diagnostic use in adults with attention deficit/hyperactivity disorder (ADHD) Eur Arch Psychiatry Clin Neurosci 256 suppl 1 3 11
29. M Rösler W Retz P Retz-Junginger J Thome T Supprian T Nissen RD Stieglitz D Blocher G Hengesch GE Trott 2004 Tools for the diagnosis of attention-deficit/hyperactivity disorder in adults. Self-rating behaviour questionnaire and diagnostic checklist Nervenarzt 75 888 895
30. T Spencer L Adler J McGough R Muniz H Jiang L Pestreich The Adult ADHD Research Group 2007 Efficacy and safety of dexmethylphenidate extended-release capsules in adults with attention-deficit/hyperactivity disorder Biol Psychiatry 61 1380 1387
31. T Spencer J Biederman T Wilens R Doyle C Surman J Prince E Mick M Aleardi K Herzig S Faraone 2005 A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder Biol Psychiatry 57 456 463
32. T Spencer T Wilens J Biederman SV Faraone JS Ablon K Lapey 1995 A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder Arch Gen Psychiatry 52 434 443
33. M Weiss C Murray 2003 Assessment and management of attention-deficit hyperactivity disorder in adults CMAJ 168 715 722
34. Wender PH (1995) Attention-deficit hyperactivity disorder in adults. Oxford University Press, New York
35. PH Wender FW Reimherr D Wood M Ward 1985 A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type, in adults Am J Psychiatry 142 547 552
36. Wittchen H-U, Zaudig M, Fydrich T (1997) SKID-I und SKID-II Strukturiertes Klinisches Interview für DSM-IV (1997). Hogrefe, Göttingen
37. DR Wood FW Reimherr PH Wender GE Johnson 1976 Diagnosis and treatment of minimal brain dysfunction in adults: a preliminary report Arch Gen Psychiatry 33 1453 1460